Import Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings from Japan

Import trade data for Indian businesses

🇯🇵 Japan — Country Profile

Capital

Tokyo

GDP (USD)

$4K

Population

125.7M

Currency

Yen

Trade Agreement

India-Japan CEPA

Import Snapshot

India imported $12.8M of medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings from Japan in 2024 -21.1% YoY.

Based on HS Code 3004 import data (UN Comtrade)

Import History — Japan to India

2024

$12.8M

HS 3004 imports

2023

$16.2M

HS 3004 imports

2022

$3.8M

HS 3004 imports

About Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings Imports from Japan

Japan is one of the supplying countries for medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings to the Indian market, classified under HS heading 3004. Indian importers source this product for domestic consumption, manufacturing inputs, or re-export.

Other Countries Supplying Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings to India

Import Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings from Japan

Get expert guidance on sourcing, customs procedures, and compliance.

Contact XIMPEX